ONO-4538HSC
Phase 1Active 0 views this week 0 watching💤 Quiet
Interest: 33/100
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Advanced or Metastatic Solid Tumors
Conditions
Advanced or Metastatic Solid Tumors
Trial Timeline
May 7, 2024 → Feb 29, 2028
NCT ID
NCT06548217About ONO-4538HSC
ONO-4538HSC is a phase 1 stage product being developed by Ono Pharmaceutical for Advanced or Metastatic Solid Tumors. The current trial status is active. This product is registered under clinical trial identifier NCT06548217. Target conditions include Advanced or Metastatic Solid Tumors.
What happened to similar drugs?
16 of 20 similar drugs in Advanced or Metastatic Solid Tumors were approved
Approved (16) Terminated (1) Active (4)
Hype Score Breakdown
Clinical
6
Activity
12
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06548217 | Phase 1 | Active |
Competing Products
20 competing products in Advanced or Metastatic Solid Tumors